 |
gefitinib |
|---|---|
| Trade Name | Iressa |
| Orphan Indication | Non-small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2014-08-26 00:00:00 |
| Sponsor | AstraZeneca Pharmaceuticals LP;1800 Concord Pike, P. O. Box 8355;Wilmington, Delaware, 19803 |
Related Access Program